-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Cerevel Therapeutics Holdings, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q1 2024.
- Cerevel Therapeutics Holdings, Inc. Return On Equity for the quarter ending March 31, 2024 was -98.9 %, a 28.2% decline year-over-year.
- Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2023 was -100 %, a 49.5% decline from 2022.
- Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2022 was -67 %, a 36.9% decline from 2021.
- Cerevel Therapeutics Holdings, Inc. annual Return On Equity for 2021 was -48.9 %, a 66.6% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)